Ex parte WANG - Page 2




                Appeal No. 1997-0094                                                                                                           
                Application No. 08/188,232                                                                                                     


                Claims 1 and 4 are illustrative:                                                                                               
                                 1.  A compound of the formula:                                                                                
                         X-Ser-Asp-Ala-Ala-Val-Asp-Thr-Ser-Ser-Glu-Ile-Thr-Thr-Lys-Asp-Leu-Z  (I)                                              
                         wherein X is an acetyl or pyroglutamyl group and                                                                      
                                 Z is  -NH ,                                                                                                   
                                               2                                                                                               
                                          -Lys-Glu-Lys-Lys-Glu-Val-Val-Glu-Glu-Ala-Glu-Asn-Pro-NH ,                                            
                                                                                                                   2                           
                                          -Lys-Glu-Lys-Lys-Glu-Val-Val-Glu-Glu-Ala-Glu-Asn-Gly-NH , or                                         
                                                                                                                   2                           
                                          -Lys-Glu-Lys-Lys-Glu-Val-Val-Glu-Glu-Ala-Glu-Asn                                                     
                         with the proviso that when X is a pyroglutamyl group, Z is -Lys-Glu-Lys-Lys-                                          
                         Glu-Val-Val-Glu-Glu-Ala-Glu-Asn, and when X is an acetyl group, Z is other                                            
                         than -Lys-Glu-Lys-Lys-Glu-Val-Val-Glu-Glu-Ala-Glu-Asn.                                                                
                                 4.  The compound of claim 1 wherein X is an acetyl group and Z is -                                           
                         Lys-Glu-Lys-Lys-Glu-Val-Val-Glu-Glu-Ala-Glu-Asn-Gly-NH (SEQ ID NO: 3).                                                
                                                                                                 2                                             
                         The prior art references of record relied on by the examiner are:                                                     
                Haritos et al. (Haritos), "Prothymosin ": Isolation and properties of the major                                                
                immunoreactive form of thymosin "  in rat thymus," Proceedings of the National Academy                                         
                                                             1                                                                                 
                of Sciences, USA, Vol. 81, pp. 1008-1011 (February 1984).                                                                      
                Zatz et al. (Zatz), "Thymosins, Lymphokines, and the Immunology of Aging," Gerontology,                                        
                Vol. 31, pp. 263-277 (1985).                                                                                                   
                Abiko et al. (Abiko II), "Synthesis and Immunological Effect of Deacetyl-thymosin "  on                                        
                                                                                                                       11                      
                Low E-Rosette-Forming Cells of a Rheumatoid Arthritis Patient," Chemical &                                                     
                Pharmaceutical Bulletin, Vol. 22, No. 12, pp. 5419-5427 (December 1985).                                                       







                                                                     - 2 -                                                                     





Page:  Previous  1  2  3  4  5  6  7  8  9  10  Next 

Last modified: November 3, 2007